# A Study To Evaluate The Pharmacokinetics, Excretion, Mass Balance and Metabolism of PF-07265803

> **NCT05286281** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 6 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-07265803

## Key facts

- **NCT ID:** NCT05286281
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-31
- **Primary completion:** 2022-05-26
- **Final completion:** 2022-05-26
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2024-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05286281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05286281, "A Study To Evaluate The Pharmacokinetics, Excretion, Mass Balance and Metabolism of PF-07265803". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05286281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*